| Literature DB >> 33978168 |
Seiko Hirota1, Hiroshi Yasuda1, Hideshi Kawakami1, Shinji Yoshinaga1.
Abstract
The Research Institute for Radiation Biology and Medicine (RIRBM) of Hiroshima University has been conducting a cohort study of atomic bomb survivors (ABS). Cohort members include those who were issued an Atomic Bomb Health Handbook from the Hiroshima local government. A series of dosimetry systems for the ABS were developed at RIRBM to evaluate the health effects associated with radiation exposure. The framework used to estimate individual doses in our dosimetry systems for ABS is mainly based on the Dosimetry System 86, and its revisions developed by the Radiation Effect Research Foundation. This article describes the design and computational principles for the dosimetry systems in RIRBM and the history of the revisions, from the first version of the system, ABS93D, to the most recent version, ABS16D. We then provide a perspective for further improvement and application of the dosimetry system.Entities:
Keywords: DS02; DS86; Hiroshima; atomic bomb survivor (ABS); dosimetry
Year: 2021 PMID: 33978168 PMCID: PMC8114224 DOI: 10.1093/jrr/rrab020
Source DB: PubMed Journal: J Radiat Res ISSN: 0449-3060 Impact factor: 2.724
Fig. 1.The relationship among free-in-air kerma, shielded kerma, organ dose, and their conversion factors.
Fig. 2.The dose on the active bone marrow in ABS16D relative to the distance (RBE = 10): (a) outdoor case. The black shows ABS93D, and the red shows ABS16D; (b) The ratio of ABS16D to ABS93D outdoors; (c) Inside a Japanese wooden house. The black shows ABS93D, and the red shows ABS16D; and (d) The ratio of ABS16D to ABS93D inside a Japanese wooden house.